Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -0.88%134.41M | 7.23%229.29M | -5.89%135.6M | 202.32%213.83M | 234.73%144.09M | 35.37%-208.98M | 13.74%-106.95M | -2.59%-323.34M | 32.05%-123.99M | -186.33%-315.17M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | -86.97%-94.6M | 0.99%-95.95M | -25.87%-50.6M | 58.94%-96.91M | -1,365.47%-40.2M | -3,298.99%-236.04M | 148.70%3.18M | 125.17%7.38M | -166,191.21%-6.52M | 50.12%-29.32M |
| Impairment and provisions: | 15.08%13.55M | -71.98%16.18M | 35.28%11.77M | -0.59%57.76M | 37.00%8.7M | 146.59%58.1M | 16.76%6.35M | -55.19%23.56M | -59.06%5.44M | 199.96%52.58M |
| -Other impairments and provisions | 11.53%12.51M | -72.46%5.06M | 28.84%11.21M | 120.61%18.38M | 37.00%8.7M | 105.96%8.33M | 16.76%6.35M | -85.54%4.04M | -26.42%5.44M | --27.98M |
| Asset sale loss (gain): | 1.63%-6.33M | 31.28%-23.51M | 73.26%-6.44M | -29.03%-34.21M | -105.70%-24.08M | -396.08%-26.51M | -157.97%-11.71M | 77.51%-5.34M | -393.08%-4.54M | 32.22%-23.77M |
| -Loss (gain) on sale of property, machinery and equipment | 1.63%-6.33M | 31.28%-23.51M | 73.26%-6.44M | -29.03%-34.21M | -105.70%-24.08M | -396.08%-26.51M | -157.97%-11.71M | 77.51%-5.34M | -393.08%-4.54M | 32.22%-23.77M |
| Depreciation and amortization: | -12.04%331.32M | -11.32%774.49M | -17.50%376.66M | -6.91%873.38M | -2.74%456.55M | -2.27%938.26M | -8.65%469.42M | -7.44%960.06M | 4.64%513.87M | 10.51%1.04B |
| -Amortization of intangible assets | -6.06%19.12M | -21.32%44.93M | -33.84%20.35M | -10.64%57.1M | -1.51%30.76M | 11.67%63.9M | -1.30%31.23M | -19.77%57.22M | -7.54%31.64M | 3.86%71.32M |
| -Other depreciation and amortization | -9.74%32.45M | 1.03%70.2M | -5.79%35.95M | -3.45%69.49M | 11.34%38.16M | 16.97%71.97M | 22.27%34.27M | 14.25%61.53M | 19.42%28.03M | 46.87%53.85M |
| Financial expense | -11.19%67.75M | 13.88%204.21M | -11.97%76.29M | -19.32%179.32M | -20.27%86.66M | -7.35%222.25M | -9.12%108.69M | 3.05%239.87M | 6.98%119.6M | 19.75%232.77M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -122.85%-1.61M | 7.25%-11.04M | 536.88%7.04M | -2,633.52%-11.9M | -116.15%-1.61M | -95.81%469.77K | 686.57%9.97M | 178.92%11.22M | -48.21%1.27M | -167.33%-14.22M |
| Accounts receivable (increase)decrease | -503.49%-14.91M | -69.52%-102.59M | 98.31%-2.47M | -175.02%-60.52M | 46.16%-146.19M | -117.04%-22.01M | -322.68%-271.54M | 234.44%129.1M | 171.37%121.94M | 192.02%38.6M |
| Accounts payable increase (decrease) | -73.91%20.19M | 260.45%173.46M | 193.89%77.4M | -110.02%-108.11M | -0.80%-82.43M | 63.64%-51.48M | 29.89%-81.78M | -175.41%-141.58M | -191.91%-116.64M | 102.27%187.75M |
| Special items of business | -624.23%-14.84M | -38.42%-12.11M | 65.70%-2.05M | -106.40%-8.75M | -335.50%-5.98M | 2,407.71%136.77M | 832.57%2.54M | 126.83%5.45M | 99.11%-346.35K | -182.64%-20.33M |
| Adjustment items of business operations | -28.07%449.77M | 15.00%1.16B | 55.73%625.25M | 50.23%1.01B | 219.56%401.49M | -25.18%674.07M | -75.39%125.64M | -22.76%900.92M | 30.46%510.44M | -20.50%1.17B |
| Net cash from operations | -30.21%434.93M | 14.80%1.15B | 57.57%623.2M | 23.81%1B | 208.58%395.51M | -10.54%810.84M | -74.87%128.17M | -20.92%906.38M | 44.83%510.1M | -23.17%1.15B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 35.80%23.85M | 381.09%62.46M | 35.24%17.56M | -71.58%12.98M | -57.08%12.98M | 164.26%45.68M | 1,580.50%30.25M | -5.10%17.29M | -87.25%1.8M | 34.03%18.22M |
| Sale of fixed assets | -51.10%12.61M | -30.56%48.09M | -38.35%25.79M | 31.85%69.26M | 278.19%41.83M | -41.57%52.53M | 79.19%11.06M | 3.98%89.91M | -76.81%6.17M | 10.04%86.46M |
| Purchase of fixed assets | -162.85%-127M | -116.04%-313.12M | 45.03%-48.32M | 41.73%-144.94M | 30.86%-87.9M | 50.94%-248.74M | 42.35%-127.15M | 46.20%-507.01M | 55.32%-220.55M | 32.22%-942.32M |
| Sale of subsidiaries | 8.51%21.4M | 1,002.62%163.85M | --19.72M | -93.61%14.86M | ---- | --232.47M | ---- | ---- | ---- | 5.09%27.69M |
| Recovery of cash from investments | 869.54%4.85M | 628.96%11.34M | 173.36%500K | 245.70%1.56M | --182.91K | -26.17%450K | ---- | -28.25%609.55K | ---- | -75.53%849.5K |
| Cash on investment | ---- | -136.77%-11.13M | ---10.62M | 86.65%-4.7M | ---- | -52.81%-35.21M | ---- | -1,041.75%-23.04M | ---- | 61.73%-2.02M |
| Other items in the investment business | ---- | ---- | ---- | -5.08%15.27M | --12.09M | --16.09M | ---- | ---- | ---- | 119.74%37.38M |
| Net cash from investment operations | -1,489.60%-64.3M | -7.85%-38.51M | 122.22%4.63M | -156.43%-35.7M | 75.74%-20.82M | 114.99%63.27M | 59.62%-85.84M | 45.43%-422.25M | 48.63%-212.58M | 47.49%-773.75M |
| Net cash before financing | -40.97%370.63M | 15.05%1.11B | 67.56%627.83M | 10.76%968.19M | 785.10%374.69M | 80.55%874.11M | -85.77%42.33M | 30.01%484.13M | 583.22%297.52M | 1,935.10%372.38M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -46.25%169.25M | -69.00%352.73M | -61.22%314.9M | -14.95%1.14B | 18.70%811.98M | -10.35%1.34B | -8.29%684.09M | -9.25%1.49B | 19.17%745.93M | 71.78%1.64B |
| Refund | 34.72%-225.57M | 55.36%-674.76M | 61.76%-345.54M | 22.43%-1.51B | -37.26%-903.5M | -30.81%-1.95B | 16.94%-658.24M | -0.34%-1.49B | -100.98%-792.52M | -276.07%-1.48B |
| Dividends paid - financing | 35.78%-19.52M | -37.84%-165.55M | 19.19%-30.39M | 33.46%-120.11M | 29.47%-37.61M | 0.55%-180.5M | 35.02%-53.33M | -18.70%-181.49M | -48.83%-82.06M | 47.45%-152.9M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | --8.06M | ---- | ---- | ---- |
| Other items of the financing business | -5.19%-171.4M | 13.57%-288.72M | 0.46%-162.95M | 13.91%-334.03M | -20.03%-163.69M | -32.94%-388.01M | 4.97%-136.38M | 0.85%-291.87M | -22.56%-143.52M | -8.11%-294.35M |
| Net cash from financing operations | -10.39%-247.24M | 6.24%-776.3M | 23.51%-223.98M | 29.80%-827.99M | -87.95%-292.82M | -150.45%-1.18B | 42.76%-155.79M | -63.65%-470.91M | -558.44%-272.17M | -7,414.12%-287.76M |
| Effect of rate | -253.80%-912.03K | 250.08%1.66M | -51.88%592.99K | -23.71%474.74K | -58.88%1.23M | 111.87%622.28K | 202.35%3M | 19.90%-5.24M | -186.14%-2.93M | -280.56%-6.54M |
| Net Cash | -69.45%123.38M | 140.84%337.63M | 393.27%403.85M | 145.92%140.19M | 172.16%81.87M | -2,410.76%-305.31M | -547.53%-113.46M | -84.39%13.21M | 1,251.35%25.35M | 280.60%84.62M |
| Begining period cash | 31.25%1.43B | 14.88%1.09B | 14.88%1.09B | -24.38%945.1M | -24.38%945.1M | 0.64%1.25B | 0.66%1.25B | 6.73%1.24B | 6.71%1.24B | 2.27%1.16B |
| Cash at the end | 3.85%1.55B | 31.25%1.43B | 44.93%1.49B | 14.88%1.09B | -9.75%1.03B | -24.38%945.1M | -9.86%1.14B | 0.66%1.25B | 8.53%1.26B | 6.71%1.24B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.